1369P - The Prevalence of Major Depressive Disorder among patients with top 10th most common cancers in S. Korea : Results from Health Insurance and Review...

Date 28 September 2014
Event ESMO 2014
Session Poster Display session
Topics Psychosocial Aspects of Cancer
Presenter Boram Park
Citation Annals of Oncology (2014) 25 (suppl_4): iv481-iv485. 10.1093/annonc/mdu352
Authors B. Park1, K. Yi2, J.S. Lee1, S. Chung2
  • 1Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, 138-736 - Seoul/KR
  • 2Psychiatry (psycho-oncology), Asan Medical Center, University of Ulsan College of Medicine, 138-736 - Seoul/KR

Abstract

Aim

Depression is a severe illness which can affect quality of life of cancer patients. The aim of this study is to explore the prevalence of major depressive disorder among patients with top 10th most common cancers in S. Korea.

Methods

We analyzed data of 1,375,832 patients from the 2011 Health Insurance and Review and Assessment service - National Patient Sample(HIRA-NPS) of S.Korea. It consisted of records for medical care and medications of 1,375,832 (3% of total records) patients from January 2011 to December 2011. We explored the proportions of patients who had been diagnosed with top 10th most common cancers in S. Korea using the ICD-10 codes. Then, we examined the prevalence of major depressive disorder(F32 and F33) among those patients.

Results

Among 1,375,832 patients sampled, thyroid cancer(N = 6688,0.49%) was the most common cancer, and colorectal(0.42%), liver (0.40%), stomach (0.37%), prostate (0.29%), breast (0.26%), lung(0.21%), pancreas(0.14%), non-hodgkin lymphoma(0.05%), and gall bladder/bile duct cancers(0.05%). The prevalence of major depressive disorder was 3.64% among all of patients sampled, but the prevalence was 10.13% among patients with any types of cancers and 10.05% among 32,622 of all patients with any of top 10th most common cancers. The prevalence of major depressive disorder was highest in pancreas cancer (15.19%) and followed by lung(14.7%), prostate (13.21%), gall bladder/bile duct (12.88%), non-hodgkin lymphoma(11.04%), colorectal (10.85%), liver (10.48%), stomach(9.95%), breast (929%), and thyroid cancer( 7.01%).

Conclusions

In this study of a nationwide population-based data, the prevalence of major depressive disorder among patients with top 10th most common cancers was higher than that of general population in S.Korea. The prevalence of major depressive disorders varied among patients with different cancer types. Clinical or psychological factors, which can affect the difference in the prevalence, need to be more precisely studied in future research.

Disclosure

All authors have declared no conflicts of interest.